REVELATION BIOSCIENCES, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
REVELATION BIOSCIENCES, INC. (REVB) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 14.20 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-16
- REVELATION BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 14.20M shares, a 125.78% increase year-over-year.
- REVELATION BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 1.82M shares, a 30.61% decline year-over-year.
- REVELATION BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 1.82M shares, a 41.79% decline year-over-year.
- REVELATION BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 6.29M shares, a 127.54% increase year-over-year.
- REVELATION BIOSCIENCES, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 2.41M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|
| 2022-03-31 | 14.20M shares 10-Q · filed 2022-05-16 | |||||
| 2021-09-30 | 1.82M shares 10-Q · filed 2021-10-29 | 1.82M shares derived: average of 2 quarters · filed 2021-10-29 | 1.82M shares 10-Q · filed 2021-10-29 | 2.69M shares derived: average of 4 quarters · filed 2022-05-16 | ||
| 2021-06-30 | 1.82M shares 10-Q · filed 2021-08-23 | 1.82M shares 10-Q · filed 2021-08-23 | 2.97M shares derived: average of 3 quarters · filed 2022-05-16 | 2.89M shares derived: average of 4 quarters · filed 2022-05-16 | ||
| 2021-03-31 | 6.29M shares 10-Q · filed 2022-05-16 | 1.82M shares 10-Q · filed 2021-06-22 | 3.55M shares derived: average of 2 quarters · filed 2022-05-16 | 3.24M shares derived: average of 3 quarters · filed 2022-05-16 | 3.21M shares derived: average of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | 813.22K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-06-16 | 1.72M shares derived: average of 2 quarters · filed 2021-10-29 | 2.19M shares derived: average of 3 quarters · filed 2021-10-29 | 2.41M shares 10-K/A · filed 2021-06-16 | 4.37M shares 10-K · filed 2021-03-31 | |
| 2020-09-30 | 2.62M shares 10-Q · filed 2021-10-29 | 2.87M shares derived: average of 2 quarters · filed 2021-10-29 | 2.94M shares 10-Q · filed 2021-10-29 | |||
| 2020-06-30 | 3.13M shares 10-Q · filed 2021-08-23 | 2.77M shares 10-Q · filed 2021-08-23 | ||||
| 2020-03-31 | 2.76M shares 10-Q · filed 2021-06-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |